2015 Venture Kick winner CellSpring makes key hires
22.01.2016
On January 16, 2016, CellSpring AG announced the hiring of two new team members, Dr. med. vet. Flurina Clement Frey and Dr. Miriam Zimmermann.
 Mauro Dell'Ambrogio, State Secretary for Education, Research and Innovation, Chris Millan, the U.S. Ambassador to Switzerland Suzan G. LeVine and Jordi Montserrat of Venture Kick at the US Embassy in Bern in September 2015.
|
 |
Dr. med. vet. Clement Frey holds a PhD from the University of Bern. She comes to CellSpring from the University of Zürich, where she worked as a study director in the Center for Applied Biotechnology and Molecular Medicine. She brings extensive experience in managing and executing research projects as well as implementation of GLP quality. Dr. Clement Frey serves as Laboratory Director at CellSpring.
Dr. Zimmermann earned a PhD from The Institute of Cancer Research (ICR) in the UK. She joins CellSpring as a Project Manager after a PostDoc in the lab of Prof. Dr. Wilhelm Krek at the ETH Zürich. Her background in tumor biology and 3D cell culture systems will accelerate the commercialization of CellSpring's 3D Bloom® Platform.
Kramer Schmidt, CEO and co-founder of CellSpring, remarked on the growing team. "We could not be more excited to bring Flurina and Miriam on board. They embody the energy, ambition, and experience that we look for in adding great people to CellSpring. These key hires will expedite our time to market and broaden our capacity to continue innovating."
About CellSpring
CellSpring brings fundamental improvements to cell-based in vitro studies. Its core technology, the “3D Bloom platform”, enables the creation of biomimetic micro tissues in a matter of minutes.
In 2015, CellSpring won the Venture Kick final, and a CHF 130,000 investment. CellSpring CEO Kramer Schmidt said, "We're thrilled to continue our journey in partnership with Venture Kick. This investment, as well as their continued guidance, is invaluable as we execute on our vision to bring greater predictive power to drug development."
The same year, among many other milestones, CellSpring CTO Chris Millan traveled to Boston and New York to explore the US market and prepare CellSpring's internationalization.